Drug Profile
E 5826
Latest Information Update: 05 Jan 2004
Price :
$50
*
At a glance
- Originator Esteve
- Developer DevCo Pharmaceuticals; Esteve
- Class Antipsychotics
- Mechanism of Action Serotonin receptor antagonists; Serotonin uptake inhibitors; Sigma receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 05 Jan 2004 No development reported - Phase-II for Schizophrenia in United Kingdom (unspecified route)
- 05 Jan 2004 No development reported - Preclinical for Schizophrenia in Spain (unspecified route)
- 26 Jun 2001 Phase-II clinical trials for Schizophrenia in United Kingdom (Unknown route)